The quarter
Alexandria Real Estate Equities reported a net loss of $73.7 million for the second quarter of 2026 on August 4. Net operating income fell 10 percent year over year. Occupancy declined to 86.9 percent from 91.7 percent in the first quarter of 2025, and by 80 basis points sequentially, which management attributed to known lease expirations and asset reclassifications rather than a single new event.
Accounts of the share reaction differ by the hour measured: Bisnow reported the stock down about 4 percent intraday to just under $49, while a separate Reuters-sourced account reported shares down 5.87 percent to $49.92 in after-hours trading from a $53.03 prior close. Both are above the year-to-date low near $40 reached in April. Adjusted per-share results also missed Wall Street expectations, with one tracking service reporting a $0.43 adjusted loss per share against a forecast $0.14 profit, even as revenue of $662.8 million edged past estimates.
Chairman Joel Marcus told the earnings call that the industry has 'decoupled from demand on the ground.' Management reaffirmed full-year FFO-per-share guidance at $6.40, plus or minus $0.05, and said the company's $2.9 billion capital-recycling program remained on track.
Volume up, price down
Leasing volume in the quarter surpassed one million square feet, roughly 60 percent above the prior quarter's pace. Rental rates on new leases fell 0.7 percent — a marked improvement on the 15 percent decline recorded in the first quarter of 2026.
Read together, those two figures describe a landlord trading price for absorption and beginning to find a level. A 15 percent rent decline followed by a 0.7 percent decline does not mean rents recovered; it means the repricing largely happened in the earlier quarter and the new leases are being signed near the reset level.
Occupancy is the lagging indicator. It falls as existing leases expire and vacated space enters the market, regardless of how briskly new deals are signed, and at 86.9 percent it reflects expirations that were negotiated years ago.
The sector backdrop, and a data conflict
Third-party market data cited alongside the results put lab rents down 5.3 percent year over year to $64 per square foot and sector vacancy at 24.3 percent, according to Cushman & Wakefield's second-quarter life-sciences report. CBRE separately reported lab and R&D vacancy at a record 23.8 percent on July 31. A JLL figure published in late August likewise put lab rents down nearly 18 percent since 2023 to about $64 per square foot, roughly consistent with the Cushman & Wakefield level even though the two firms compute the metric differently.
The tenant mix in Alexandria's own leasing points to where demand is concentrated: the company said the quarter's activity was led by life-science tools and advanced-technology tenants rather than the traditional biopharma base that anchored the sector's pandemic-era expansion. That is consistent with brokers' description of a market where operators are landing deals only through heavy concessions.
Caveat: the quarterly financial figures are the company's own, disclosed in its earnings materials; the market-wide vacancy and rent figures are proprietary brokerage research, which is not independently auditable. The relationship between Alexandria's portfolio performance and the national averages is not a like-for-like comparison.